Navigation Links
Novelos Therapeutics Announces Dismissal of Putative Federal Securities Class Action Lawsuit
Date:6/28/2011

nd uncertainties that may cause actual future experience and results to differ materially from the statements made.  These statements are based on our current beliefs and expectations as to such future outcomes.  Drug discovery and development involve a high degree of risk.  Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our  pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement.


'/>"/>
SOURCE Novelos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Novelos Therapeutics to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16
2. Nonconformity of NOV002 Used in Phase 3 NSCLC Trial Sponsored by Novelos Therapeutics, Inc to NOV002 (Glutoxim(R)), Used in Phase 1/2 NSCLC and all Previous Trials
3. Echo Therapeutics Announces NASDAQ Listing
4. Cell Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes
5. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
6. Amsterdam Molecular Therapeutics Receives Opinion on Glybera(R) Marketing Authorisation Application
7. Sirnaomics Seals a Second Partnership Deal with a Chinese Pharmaceutical Company for Developing siRNA Therapeutics
8. Alzheimers Drug Discovery Foundation Supports Axxam To Develop Novel Therapeutics for Alzheimers Disease
9. Reportlinker Adds U.S. Retinal Therapeutics Market
10. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
11. Pearl Therapeutics Advances Its Long-Acting Bronchodilator Combination Product Candidate into Four Additional Phase 2 Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Huntington Memorial ... Valley to perform transcatheter aortic valve replacement (TAVR), a ... is a revolutionary new way to replace an aortic ... a heart lung machine. The procedure is ... led by Azhil ( Alex) Durairaj , MD, interventional ...
(Date:3/26/2015)... , March 26, 2015 When ... by their existing PACS vendor their system would ... determined that they needed a better structured solution ... selected Avreo interWORKS due to its interface capabilities ... meaningful use standards through to the hospital,s radiology ...
(Date:3/26/2015)... Calif. , March 26, 2015  Desert Valley ... Nation five times , is the first U.S. ... in its emergency department to help clinicians prevent hospital ... Victorville, Calif. , is a community ... bariatric patients.  Using the Leaf Patient Monitor in the ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... Inc. (Nasdaq: AKRX ) will host a conference ... results followed by a Q&A session.  The company will release ... Akorn Third Quarter 2010 Conference CallDate/Time: , Tuesday, ... (888) 215-6895International Callers: , (913) 312-0860Confirmation Code: ...
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) announced ... offering of 5,500,000 shares of Common Stock, as well ... to the full exercise of the over-allotment option granted ... (before estimated offering expenses) were approximately $175.1 million.  Citi ...
Cached Medicine Technology:Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock 2Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock 3
(Date:3/26/2015)... March 26, 2015 Innovative research ... aneurysms and preventing often fatal ruptures, says The ... to raising awareness of brain aneurysms and funding ... has captured national attention with the death ... who died last Friday after suffering a ruptured ...
(Date:3/26/2015)... March 26, 2015 The ... Patients’ Access to Treatments Act (PATA) that was ... by Reps. David B. McKinley (R-WV) and Lois ... cost-sharing requirements for medications placed in a specialty ... reducing patients’ out-of-pocket expenses. , This legislation is ...
(Date:3/26/2015)... March 26, 2015 In preparation for ... Fitness Revolution, founded by Samir Becic, has issued ... own personal health and fitness, as well as their ... The list includes Sen. Ted Cruz, who has officially ... as all other politicians who have shown interest in ...
(Date:3/26/2015)... Md. (PRWEB) March 26, 2015 Los ... in a pageant. Not until last year, when she ... Eliana has pulmonary hypertension (PH) – a debilitating disease ... heart and can lead to right-heart failure. The disease ... born in 2003. Lyndsi entered the pageant to raise ...
(Date:3/26/2015)... 2015 DiabetesSisters is pleased to announce ... of $25,000 for a groundbreaking project in the field ... a partnering organization, The Society for Women’ Health Research, ... on women and diabetes. The “Women & Diabetes: 10Q ... research to improve the health and wellbeing of women ...
Breaking Medicine News(10 mins):Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:DiabetesSisters Receives Financial Support for Landmark Report from Janssen Pharmaceuticals 2
... ban by the government, asbestos might still be illegally ... toxic mineral on a large scale, a Canadian social// ... working on mining issues in Canada for 12 years, ... with asbestos mining. ,Palu, accompanied by a ...
... Female genital mutilation (FGM), excision of clitoris is practiced ... without the use of anesthetics. A senior doctor ... that is going on for generations, sorting out the ... published on bmj.com last month probes that the procedure ...
... throughout the country to manage over six million children ... Madras ENT Rearch Foundation Charitable Trust Mohan Kameshwaran said ... concentrated in major cities, which made treatment and rehabilitation ... to the inauguration of the MERF Institute of Speech ...
... -- intrauterine insemination with controlled ovarian hyperstimulation – is only ... for some couples. ,The results of the study ... research was conducted on 253 couples with unexplained infertility who'd ... cases where no obvious abnormalities were found. ,The ...
... type-1 diabetes are more prone to develop multiple sclerosis ... reveals.// ,Both type-1 diabetes and MS are ... immune response against itself, attacking insulin-producing cells in patients ... in those suffering from MS. , Dr. ...
... to thicken everything from baby food to sexual lubricants ... and genital warts. ,Researchers found the thickener, ... cells in laboratory tests. Certain strains of HPV can ... the study conducted by researchers from the National Cancer ...
Cached Medicine News:Health News:Despite Ban, Asbestos Produce Goes Unhindered 2Health News:Common Chemical From Seaweed Could Help In The Fight Against Cervical Cancer Virus-HPV 2
... a high resolution diagnostic test for cholesterol components ... The test procedure is simple and can be ... value is clearly flagged. A color coded profile ... LDL in red and the good HDL in ...
... This control is designed to validate ... and apolipoprotein testing methods. This control is ... Series, Cobas, Dimension, Hitachi, Synchron and Vitros. ... methods and HDL precipitation methods: Dextran Sulfate ...
... control monitors spinal fluid analyte methods to ... Control is packaged in dropper-tip bottles for ... need for pipets and minimizing waste. Values ... major chemistry analyzers and nephelometers: Abbott Aeroset, ...
... Suitable for use with ... BR2 bilirubinometers (pediatric) and all ... instruments including Aeroset, AU Series, ... Vitros. These controls contain purified ...
Medicine Products: